FTC challenges deceptive claims and “selfie” news and reviews for alcohol treatment product
For the millions of Americans struggling to reduce their alcohol intake or stop drinking altogether, a product called Sobrenix sounded like the answer. But according to the FTC, defendants Rejuvica LLC and corporate officers Kyle Armstrong and Kyle Dilger made numerous unsubstantiated representations and falsely claimed to have clinical proof that didn’t really exist, in violation of both the Opioid Addiction Recovery Fraud Prevention Act and the FTC Act. What’s more, the complaint alleges they made deceptive use of endorsements – both by having paid endorsers make TV appearances designed to look like independent news stories, but that were actually paid advertising and by creating a phony “review” website. The proposed settlement includes a financial remedy that will return money to consumers.